ZetrOZ Systems’ sam(R) Wearable Ultrasound Device Honored for Innovation

ZetrOZ Systems, known for its sustained acoustic medicine technology, has been recognized as the Top Wearable Technology Solutions Provider for 2024 by Applied Technology Review. This accolade highlights the sam® wearable ultrasound medical device for its groundbreaking role in promoting soft tissue healing without the need for surgery or injections.

Applied Technology Review commended ZetrOZ’s sam® X1 Device, which provides untethered mechanobiology treatment, operating automatically on the body for several hours daily. This approach contrasts with more invasive treatments like surgeries or injections.

George K. Lewis, founder and CEO of ZetrOZ Systems, expressed satisfaction over the recognition, noting the award's role in spreading awareness about their devices' efficacy in treating soft tissue injuries and accelerating healing.

ZetrOZ’s sam® devices offer long-duration, high-frequency, low-intensity ultrasound treatment. They have received U.S. FDA clearance for multiple conditions, including knee osteoarthritis and chronic back pain. The technology's effectiveness is supported by 42 peer-reviewed publications and 20 clinical studies.